瑞士-PO 2025:推进癌症突变和精密瘤学的结构分析,使用最新的版本
Fanny S Krebs1,2, Olivier Michielin2,3, Vincent Zoete1,2
1Computer-aided Molecular Engineering, Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.
JCO precision oncology
|March 2, 2026
概括
瑞士PO平台现在集成了广泛的基因组数据和分析工具,以帮助解释致癌基因突变. 这种增强的资源支持精确的瘤学研究和癌症变体的临床决策.
科学领域:
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
- 基因组学就是基因组学.
背景情况:
- 精密瘤学正在迅速识别新的瘤驱动基因和变异.
- 这导致突变的增加,其功能影响尚不清楚.
- 越来越需要先进的分子建模工具来解释变异.
研究的目的:
- 扩大和重新设计瑞士PO平台.
- 整合大规模的基因组数据与基于结构和序列的分析工具.
- 在临床和研究环境中支持变异解释.
主要方法:
- 集成的oncodriver基因数据,多重序列对齐 (MSA) 和3D结构预测/可视化.
- 开发了用于BRAF激酶突变分类和蛋白质-连接体相互作用的模块.
- 统一的外部数据库集成用于多维分析.
主要成果:
- 更新后的瑞士-PO平台包括1500个oncodriver基因,300万个突变,26000个3D结构,4000个MSA和20万个连接体的数据.
- 纳入了BRAF激酶突变类预测器,用于治疗决策.
- 建立了瑞士-PO作为精密瘤学的综合资源.
结论:
- 增强的瑞士PO作为解释癌症相关突变的强大资源.
- 它有助于瘤学家,生物信息学家和分子生物学家在推进精密医学方面取得进展.
- 该平台可以在Swiss-PO.com上访问.
更多相关视频
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
12.3K
05:56Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
Published on: October 13, 2022
1.9K
相关概念视频
02:18Cancer
55.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.2K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K